January 23, 2018
U.S. FDA OK’s Baxter’s ready-to-use cardiovascular medication Bivalirudin
Baxter International has announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection…
Pharmaceuticals, Biotechnology and Life Sciences
Baxter International has announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection…